More Articles


Stop Releasing Your Data Into The Wild

Paul Simms, (Sep 12, 2018)

You don't have to give your data away for free. In fact, it is in everyone's interests that you don't.
Patients and Medical

Co-Creation With Patients: A Stellar Combo?

Hugh Gosling, (Sep 5, 2018)

Only by working closely with patients can pharma deliver the best products and services. Read our practical guide to co-creating with patients.
Access and Evidence

Could Digital Medicines Improve Access For All?

Danielle Barron, (Sep 4, 2018)

Digital medicines could provide a new roadmap to reimbursement and regulatory approval.

Beyond The Spiel

Danielle Barron, (Aug 31, 2018)

Pharma companies are now offering more than just the medicine, which means marketers have to go that extra mile too.

Want To Emulate A Startup? Here’s How.

Paul Simms, (Aug 28, 2018)

eyeforpharma Chairman, Paul Simms, explains why pharma companies are failing to innovate as they chase short-term revenues.

Wearables: This Season’s Must-Have Marketing Accessory

Andrew Stone, (Aug 21, 2018)

Medical devices are generating real-world data on patient populations. Are marketers making the most of this opportunity?
Access and Evidence

Talking The Same Language

Adam Chapman, (Aug 10, 2018)

A universal standard for real-world evidence no longer seems quixotic. But how are companies going to do it?
Patients and Medical

Why Patient Organizations Are No Summer Fling For Pharma

Adam Chapman, (Aug 8, 2018)

Pharma companies are forming long-term relationships with patient organizations, a move that is already bearing fruits for both parties.
Access and Evidence

Going Through the Motions

Adam Chapman, (Aug 6, 2018)

Both pharma and payers say they need to talk more, but are they really listening?
Access and Evidence

Navigating the Chaos

Adam Chapman, (Aug 6, 2018)

With the access landscape shifting rapidly, pharma needs to watch its step